The new treatment is the first FDA-approved drug to address the overproduction of cortisol in Cushing disease by blocking the enzyme known as 11-beta-hydroxylase and preventing cortisol synthesis.
New research offers insight on survival outcomes in patients with end-stage renal disease who undergo hemodialysis at home vs in-center. The findings were presented at ASN Kidney Week 2018.
Although rescheduling a missed hemodialysis appointment can help reduce the risk of subsequent hospitalization, it likely cannot eliminate this risk, according to new research presented at the Am
By Marilynn Larkin
NEW YORK (Reuters Health) - Benign, so-called "nonfunctional" adrenal tumors may increase the risk of type 2 diabetes, researchers report.
<p>Nuclear medicine imaging significantly improves the ability to localize the tumor in ectopic Cushing's syndrome, according to a new systematic review.</p>
